Duodenal-Jejunal Bypass Improves Glycemia and Decreases SGLT1-Mediated Glucose Absorption in Rats With Streptozotocin-Induced Type 2 Diabetes

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Annals of Surgery

• Publication date

  2013-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/SLA.0b013e3182890311PMID 23478528
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Jejunal nutrient sensing is required for duodenal-jejunal bypass surgery to rapidly lower glucose concentrations in uncontrolled diabetes

  2012cited by this paper
• Duodenal-jejunal bypass protects GK rats from {beta}-cell loss and aggravation of hyperglycemia and increases enteroendocrine cells coexpressing GIP and GLP-1.

  2011cited by this paper
• Comparative expression of hexose transporters (SGLT1, GLUT1, GLUT2 and GLUT5) throughout the mouse gastrointestinal tract

  2011cited by this paper
• Na+-d-glucose Cotransporter SGLT1 is Pivotal for Intestinal Glucose Absorption and Glucose-Dependent Incretin Secretion

  2011cited by this paper
• Duodenal–Jejunal Bypass Surgery Does Not Increase Skeletal Muscle Insulin Signal Transduction or Glucose Disposal in Goto–Kakizaki Type 2 Diabetic Rats

  2011cited by this paper
• Bypassing the Duodenum Does Not Improve Insulin Resistance Associated With Diet‐Induced Obesity in Rodents

  2010cited by this paper
• Restricted feeding phase shifts clock gene and sodium glucose cotransporter 1 (SGLT1) expression in rats.

  2010cited by this paper
• Antiangiogenic effects of indole-3-carbinol and 3,3'-diindolylmethane are associated with their differential regulation of ERK1/2 and Akt in tube-forming HUVEC.

  2010cited by this paper
• Ileal Interposition Improves Glucose Tolerance in Low Dose Streptozotocin-treated Diabetic and Euglycemic Rats

  2009cited by this paper
• Duodenal-Jejunal Exclusion Improves Glucose Tolerance in the Diabetic, Goto-Kakizaki Rat by a GLP-1 Receptor-Mediated Mechanism

  2009cited by this paper
• Diurnal expression of the rat intestinal sodium-glucose cotransporter 1 (SGLT1) is independent of local luminal factors.

  2009cited by this paper
• First-Phase Insulin Secretion Restoration and Differential Response to Glucose Load Depending on the Route of Administration in Type 2 Diabetic Subjects After Bariatric Surgery

  2009cited by this paper
• The Characterization of High-Fat Diet and Multiple Low-Dose Streptozotocin Induced Type 2 Diabetes Rat Model

  2009cited by this paper
• Endocrine mechanisms mediating remission of diabetes after gastric bypass surgery

  2009cited by this paper
• Impact of Roux-en-Y gastric bypass surgery on rat intestinal glucose transport.

  2009cited by this paper
• Do Incretins Play a Role in the Remission of Type 2 Diabetes after Gastric Bypass Surgery: What are the Evidence?

  2009cited by this paper
• Nutrient-dependent secretion of glucose-dependent insulinotropic polypeptide from primary murine K cells

  2009cited by this paper
• Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis.

  2009cited by this paper
• Coordinated, diurnal hexose transporter expression in rat small bowel: implications for small bowel resection.

  2008cited by this paper
• Revised immunolocalization of the Na+-D-glucose cotransporter SGLT1 in rat organs with an improved antibody.

  2008cited by this paper
• Ileal Transposition Controls Diabetes as Well as Modified Duodenal Jejunal Bypass With Better Lipid Lowering in a Nonobese Rat Model of Type II Diabetes by Increasing GLP-1

  2008cited by this paper
• Is Type 2 Diabetes an Operable Intestinal Disease?

  2008cited by this paper
• Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial.

  2008cited by this paper
• Sugar absorption in the intestine: the role of GLUT2.

  2008cited by this paper
• Diurnal rhythmicity in glucose uptake is mediated by temporal periodicity in the expression of the sodium-glucose cotransporter (SGLT1).

  2008cited by this paper
• Glucose Sensing in L Cells: A Primary Cell Study

  2008cited by this paper
• Biology of incretins: GLP-1 and GIP.

  2007cited by this paper
• The physiology of glucagon-like peptide 1.

  2007cited by this paper
• The effects of duodenal-jejunal exclusion on hormonal regulation of glucose metabolism in Goto-Kakizaki rats.

  2007cited by this paper
• Tripeptides of RS1 (RSC1A1) Inhibit a Monosaccharide-dependent Exocytotic Pathway of Na+-d-Glucose Cotransporter SGLT1 with High Affinity*

  2007cited by this paper
• How the hindgut can cure type 2 diabetes. Ileal transposition improves glucose metabolism and beta-cell function in Goto-kakizaki rats through an enhanced Proglucagon gene expression and L-cell number.

  2007cited by this paper
• The Mechanism of Diabetes Control After Gastrointestinal Bypass Surgery Reveals a Role of the Proximal Small Intestine in the Pathophysiology of Type 2 Diabetes

  2006cited by this paper
• The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes.

  2006cited by this paper
• The Glucagon‐Like Peptides

  2006cited by this paper
• Laparoscopic Roux-en-Y gastric bypass for BMI < 35 kg/m(2): a tailored approach.

  2006cited by this paper
• Mice without the Regulator Gene Rsc1A1 Exhibit Increased Na+-d-Glucose Cotransport in Small Intestine and Develop Obesity

  2005cited by this paper
• Weight loss through ileal transposition is accompanied by increased ileal hormone secretion and synthesis in rats.

  2005cited by this paper
• Surgery decreases long-term mortality, morbidity, and health care use in morbidly obese patients.

  2005cited by this paper
• Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening.

  2005cited by this paper
• Effect of Duodenal–Jejunal Exclusion in a Non-obese Animal Model of Type 2 Diabetes: A New Perspective for an Old Disease

  2004cited by this paper
• Effect of duodenal-jejunal exclusion in a non-obese animal model of type 2 diabetes: a new perspective for an old disease.

  2004cited by this paper
• Bariatric surgery: a systematic review and meta-analysis.

  2004cited by this paper
• Surgery Decreases Long-term Mortality, Morbidity, and Health Care Use in Morbidly Obese Patients

  2004cited by this paper
• Gluco-incretins control insulin secretion at multiple levels as revealed in mice lacking GLP-1 and GIP receptors.

  2004cited by this paper
• Expression of monosaccharide transporters in intestine of diabetic humans.

  2002cited by this paper
• Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes

  2002cited by this paper
• A new mathematical model for relative quantification in real-time RT-PCR.

  2001cited by this paper
• Evaluation of absorption kinetics of orally administered theophylline in rats based on gastrointestinal transit monitoring by gamma scintigraphy.

  2001cited by this paper
• Changes in the levels of intestinal Na+/glucose co-transporter (SGLT1) in experimental diabetes.

  1997cited by this paper
• Acute increase by portal insulin in intestinal glucose absorption via hepatoenteral nerves in the rat.

  1996cited by this paper
• Immunohistochemical localization of Na+-dependent glucose transporter in the rat digestive tract

  1995cited by this paper
• Small intestine hexose transport in experimental diabetes. Increased transporter mRNA and protein expression in enterocytes.

  1994cited by this paper
• Differential responses of intestinal glucose transporter mRNA transcripts to levels of dietary sugars.

  1993cited by this paper
• Altered glucose carrier expression: mechanism of intestinal adaptation during streptozocin-induced diabetes in rats.

  1991cited by this paper
• Ontogenic development of lamb intestinal sodium‐glucose co‐transporter is regulated by diet.

  1991cited by this paper
• Specific regulation of intestinal nutrient transporters by their dietary substrates.

  1989cited by this paper
• Diabetogenic action of streptozotocin: relationship of dose to metabolic response.

  1969cited by this paper
• Analysis of Covariance Based on General Rank Scores

  1969cited by this paper

• Atypical protein kinase C activation drives intestinal glucose excretion in diabetes mellitus.

  2026cites this paper
• Duodenal-jejunal bypass ameliorates MASLD in rats by regulating gut microbiota and bile acid metabolism through FXR pathways

  2025cites this paper
• Duodenal–Jejunal Bypass Restores Sweet Taste Receptor-Mediated Glucose Sensing and Absorption in Diabetic Rats

  2024cites this paper
• The effect of bariatric surgery on the expression of gastrointestinal taste receptors: A systematic review

  2024cites this paper
• Sodium-glucose co-transporter 1 (SGLT1) differentially regulates gluconeogenesis and GLP-1 receptor (GLP-1R) expression in different diabetic rats: a preliminary validation of the hypothesis of “SGLT1 bridge” as an indication for “surgical diabetes”

  2022cites this paper
• Role of Proximal Intestinal Glucose Sensing and Metabolism in the Blood Glucose Control in Type 2 Diabetic Rats After Duodenal Jejunal Bypass Surgery

  2022cites this paper
• Sleeve gastrectomy suppresses hepatic de novo cholesterogenesis and improves hepatic cholesterol accumulation in obese rats with type 2 diabetes mellitus.

  2021cites this paper
• The Role of Gut Microbiota in Duodenal-Jejunal Bypass Surgery-Induced Improvement of Hepatic Steatosis in HFD-Fed Rats

  2021cites this paper
• Renal denervation ameliorates cardiac metabolic remodeling in diabetic cardiomyopathy rats by suppressing renal SGLT2 expression

  2021cites this paper
• Ileal transposition helps to regulate plasma hepatokine levels in obese Zucker (Crl:ZUC(ORL)-Leprfa) rats

  2021cites this paper
• Glucose transporters in the small intestine in health and disease

  2020cites this paper
• DUODENAL-JEJUNAL BYPASS REDUCES LIPID ACCUMULATION IN THE BROWN ADIPOSE TISSUE OF HYPOTHALAMIC OBESE RATS

  2020cites this paper
• Serum glucose excretion after Roux-en-Y gastric bypass: a potential target for diabetes treatment

  2020cites this paper
• Enteroendocrine Hormone Secretion and Metabolic Control: Importance of the Region of the Gut Stimulation

  2020cites this paper
• Single-Anastomosis Duodenal Jejunal Bypass Improve Glucose Metabolism by Regulating Gut Microbiota and Short-Chain Fatty Acids in Goto-Kakisaki Rats

  2020cites this paper
• Duodenojejunal Bypass Plus Sleeve Gastrectomy Reduces Infiltration of Macrophages and Secretion of TNF-α in the Visceral White Adipose Tissue of Goto-Kakizaki Rats

  2019cites this paper
• Establishing a successful rat model of duodenal- jejunal bypass: A detailed guide

  2018cites this paper
• Reduction of DNA damage in peripheral lymphocytes of obese patients after bariatric surgery-mediated weight loss

  2018cites this paper
• Effects of duodenal-jejunal bypass on structure of diaphragm in western diet obese rats.

  2017cites this paper
• Duodenal-Jejunal Bypass Surgery Increased GLP-1 Receptor Expression in Enteric Nervous System of STZ-Induced Diabetic Rats

  2017cites this paper
• Influence of Lactase on the In Vitro and In Vivo Antiglycaemic Effects of Onion Flavonoids

  2017cites this paper
• Duodenal-Jejunal Bypass Surgery Reverses Diabetic Phenotype and Reduces Obesity in db/db Mice

  2017cites this paper
• Gastric Bypass-Related Effects on Glucose Control, β Cell Function and Morphology in the Obese Zucker Rat

  2016cites this paper
• Sodium glucose transport modulation in type 2 diabetes and gastric bypass surgery.

  2016cites this paper
• Intestinal SGLT 1 in metabolic health and disease

  2016cites this paper
• Intestinal SGLT1 in metabolic health and disease.

  2016cites this paper
• Phosphorylation of RS1 (RSC1A1) Steers Inhibition of Different Exocytotic Pathways for Glucose Transporter SGLT1 and Nucleoside Transporter CNT1, and an RS1-Derived Peptide Inhibits Glucose Absorption

  2016cites this paper
• Roux-en-Y Gastric Bypass Surgery Suppresses Hepatic Gluconeogenesis and Increases Intestinal Gluconeogenesis in a T2DM Rat Model

  2016cites this paper
• Changes in Glucose Transporters, Gluconeogenesis, and Circadian Clock after Duodenal–Jejunal Bypass Surgery

  2015cites this paper
• Dumping-Syndrom

  2015cites this paper
• Ileal Interposition in Rats with Experimental Type 2 Like Diabetes Improves Glycemic Control Independently of Glucose Absorption

  2015cites this paper
• Expedited Biliopancreatic Juice Flow to the Distal Gut Benefits the Diabetes Control After Duodenal-Jejunal Bypass

  2015cites this paper
• Duodenal-Jejunal Bypass Restores Insulin Action and Βeta-Cell Function in Hypothalamic-Obese Rats

  2015cites this paper
• From molecule to men: Inhibition of intestinal glucose absorption by polyphenols and plant extracts for reducing the glycemic response

  2014cites this paper
• Duodenal-Jejunal Bypass Surgery Suppresses Hepatic De Novo Lipogenesis and Alleviates Liver Fat Accumulation in a Diabetic Rat Model

  2014cites this paper
• Duodenal–Jejunal Bypass Improves Glucose Homeostasis in Association with Decreased Proinflammatory Response and Activation of JNK in the Liver and Adipose Tissue in a T2DM Rat Model

  2014cites this paper
• Roux-en Y Gastric Bypass Is Superior to Duodeno-Jejunal Bypass in Improving Glycaemic Control in Zucker Diabetic Fatty Rats

  2014cites this paper
• Duodenal jejunal bypass attenuates non-alcoholic fatty liver disease in western diet-obese rats.

  2014cites this paper
• Taste receptors of the gut: emerging roles in health and disease

  2013cites this paper